GHK-Cu: Copper Tripeptide in Matrix Research

GHK-Cu (glycyl-L-histidyl-L-lysine:copper(II)) is a naturally occurring tripeptide-copper complex first isolated from human plasma by Pickart and Thaler in 1973. Its characteristic blue coloration — visible in the lyophilized powder — reflects the copper(II) chelation through the histidine imidazole nitrogen and the two flanking backbone amines. Since its initial characterization, GHK-Cu has become one of the most extensively studied copper-peptide constructs in in-vitro research settings.

Structure and Copper Chelation

The tripeptide sequence Gly-His-Lys forms a high-affinity square-planar chelate with Cu(II) via the imidazole nitrogen of histidine, the alpha-amine of glycine, and the deprotonated amide nitrogens of the Gly-His peptide bond. This geometry creates a stable 1:1 Cu(II) complex with binding constants in the nanomolar range, making GHK-Cu one of the highest-affinity endogenous copper carriers identified in plasma.

The copper association is critical to the compound's research utility. Free GHK peptide and GHK-Cu exhibit distinct behaviors in cell-culture assays, underscoring that the biological activity studied in most in-vitro models is associated with the intact complex rather than the peptide backbone alone.

Matrix Remodeling Research Applications

The majority of peer-reviewed in-vitro research involving GHK-Cu focuses on its interactions with extracellular matrix (ECM) components and the enzymes that regulate matrix turnover. Studies in dermal fibroblast cell models have examined GHK-Cu's effects on collagen type I and III gene expression, fibronectin, and decorin. These experiments generally use GHK-Cu as a reference compound to interrogate matrix remodeling pathways rather than as a therapeutic candidate.

Matrix metalloproteinase (MMP) studies represent another active research area. GHK-Cu has been used to probe differential expression of MMP-2 (gelatinase A) and tissue inhibitors of metalloproteinases (TIMPs) in in-vitro wound-model systems. Understanding how copper-peptide complexes modulate the MMP/TIMP axis is relevant to basic connective-tissue biology and to assay development for screening MMP-modulating compounds.

Copper Biology and Superoxide Dismutase Mimicry

Beyond matrix biology, GHK-Cu has been examined as a model copper carrier in studies of copper homeostasis and in assays probing superoxide dismutase (SOD)-like activity. Cu(II) complexes in the right coordination geometry can catalyze the dismutation of superoxide, and GHK-Cu has been used as a reference construct in comparative studies of copper-peptide catalysis. These applications are purely in-vitro and serve the goal of understanding copper-peptide coordination chemistry rather than producing any clinical effect.

Research Considerations

GHK-Cu is supplied as the copper(II) complex in lyophilized form. At DRAGNZ PEPS, each batch is tested at ≥99% purity by RP-HPLC and released at 50 mg per vial — a quantity suited to multi-run cell-culture experiments. Researchers should note that GHK-Cu is hygroscopic after reconstitution; working aliquots should be prepared fresh and stored refrigerated, with long-term stock maintained as lyophilized powder at −20°C.

For in-vitro studies, GHK-Cu is typically reconstituted in sterile phosphate-buffered saline (PBS) or bacteriostatic water. Concentration ranges in published cell-culture research span from low nanomolar to low micromolar depending on the endpoint being measured — consult primary literature for assay-specific protocols.